Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination.

Vandepapeliere P, Barrasso R, Meijer CJ, Walboomers JM, Wettendorff M, Stanberry LR, Lacey CJ.

J Infect Dis. 2005 Dec 15;192(12):2099-107. Epub 2005 Nov 11.

PMID:
16288373
2.

Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia.

Elfgren K, Jacobs M, Walboomers JM, Meijer CJ, Dillner J.

Obstet Gynecol. 2002 Nov;100(5 Pt 1):965-71.

PMID:
12423862
3.

Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study.

Moreno V, Bosch FX, Muñoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S; International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group.

Lancet. 2002 Mar 30;359(9312):1085-92.

PMID:
11943255
4.

Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland.

Cruz I, Napier SS, van der Waal I, Snijders PJ, Walboomers JM, Lamey PJ, Cowan CG, Gregg TA, Maxwell P, Meijer CJ.

J Clin Pathol. 2002 Feb;55(2):98-104.

5.

Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines.

Smith JS, Muñoz N, Herrero R, Eluf-Neto J, Ngelangel C, Franceschi S, Bosch FX, Walboomers JM, Peeling RW.

J Infect Dis. 2002 Feb 1;185(3):324-31. Epub 2002 Jan 17.

PMID:
11807714
6.

TP53 polymorphism, HPV infection, and risk of cervical cancer.

Klug SJ, Wilmotte R, Santos C, Almonte M, Herrero R, Guerrero I, Caceres E, Peixoto-Guimaraes D, Lenoir G, Hainaut P, Walboomers JM, Muñoz N.

Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):1009-12.

7.

Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line.

Steenbergen RD, Kramer D, Meijer CJ, Walboomers JM, Trott DA, Cuthbert AP, Newbold RF, Overkamp WJ, Zdzienicka MZ, Snijders PJ.

J Natl Cancer Inst. 2001 Jun 6;93(11):865-72.

PMID:
11390536
8.

High prevalence of human papillomavirus infection in Mexican males: comparative study of penile-urethral swabs and urine samples.

Lazcano-Ponce E, Herrero R, Muñoz N, Hernandez-Avila M, Salmerón J, Leyva A, Meijer CJ, Walboomers JM.

Sex Transm Dis. 2001 May;28(5):277-80.

PMID:
11354266
9.

Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase.

Hooijberg E, Ruizendaal JJ, Snijders PJ, Kueter EW, Walboomers JM, Spits H.

J Immunol. 2000 Oct 15;165(8):4239-45.

10.

PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes.

Rozendaal L, Westerga J, van der Linden JC, Walboomers JM, Voorhorst FJ, Risse EK, Boon ME, Meijer CJ.

J Clin Pathol. 2000 Aug;53(8):606-11.

11.

Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity.

Kjaer SK, Svare EI, Worm AM, Walboomers JM, Meijer CJ, van den Brule AJ.

Sex Transm Dis. 2000 Sep;27(8):438-45.

PMID:
10987448
12.

[Human papillomavirus and screening for cervical cancer: state of art and prospects].

Meijer CJ, Rozendaal L, Voorhorst FJ, Verheijen R, Helmerhorst TJ, Walboomers JM.

Ned Tijdschr Geneeskd. 2000 Aug 26;144(35):1675-9. Review. Dutch.

PMID:
10981235
13.

[Human papillomavirus and the development of cervical cancer: concept of carcinogenesis].

Walboomers JM, Meijer CJ, Steenbergen RD, van Duin M, Helmerhorst TJ, Snijders PJ.

Ned Tijdschr Geneeskd. 2000 Aug 26;144(35):1671-4. Review. Dutch.

PMID:
10981234
14.

Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia.

Bontkes HJ, de Gruijl TD, van den Muysenberg AJ, Verheijen RH, Stukart MJ, Meijer CJ, Scheper RJ, Stacey SN, Duggan-Keen MF, Stern PL, Man S, Borysiewicz LK, Walboomers JM.

Int J Cancer. 2000 Oct 1;88(1):92-8.

15.

p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management.

Cruz IB, Meijer CJ, Snijders PJ, Snow GB, Walboomers JM, van Der Waal I.

J Pathol. 2000 Jun;191(2):132-7.

PMID:
10861571
16.

Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types.

Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ.

Int J Cancer. 2000 Jul 15;87(2):221-7.

17.

High risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy.

Hopman EH, Rozendaal L, Voorhorst FJ, Walboomers JM, Kenemans P, Helmerhorst TJ.

BJOG. 2000 May;107(5):600-4.

18.

A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears.

Jacobs MV, Zielinski D, Meijer CJ, Pol RP, Voorhorst FJ, de Schipper FA, Runsink AP, Snijders PJ, Walboomers JM.

Br J Cancer. 2000 Apr;82(8):1421-6.

19.

Cervical cytology after 2000: where to go?

Meijer CJ, Walboomers JM.

J Clin Pathol. 2000 Jan;53(1):41-3. Review. No abstract available.

20.

No direct role for Epstein-Barr virus in oral carcinogenesis: a study at the DNA, RNA and protein levels.

Cruz I, Van Den Brule AJ, Brink AA, Snijders PJ, Walboomers JM, Van Der Waal I, Meijer CJ.

Int J Cancer. 2000 May 1;86(3):356-61.

21.

Human papillomavirus infection and invasive cervical cancer in Paraguay.

Rolón PA, Smith JS, Muñoz N, Klug SJ, Herrero R, Bosch X, Llamosas F, Meijer CJ, Walboomers JM.

Int J Cancer. 2000 Feb 15;85(4):486-91.

22.

Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis.

van Duin M, Snijders PJ, Vossen MT, Klaassen E, Voorhorst F, Verheijen RH, Helmerhorst TJ, Meijer CJ, Walboomers JM.

J Gen Virol. 2000 Feb;81(Pt 2):317-25.

PMID:
10644829
23.

Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison.

Jacobs MV, Snijders PJ, Voorhorst FJ, Dillner J, Forslund O, Johansson B, von Knebel Doeberitz M, Meijer CJ, Meyer T, Nindl I, Pfister H, Stockfleth E, Strand A, Wadell G, Walboomers JM.

J Clin Pathol. 1999 Jul;52(7):498-503. Erratum in: J Clin Pathol 1999 Oct;52(10):790.

24.
25.

Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma.

Sun Y, Eluf-Neto J, Bosch FX, Muñoz N, Walboomers JM, Meijer CJ, Shah KV, Clayman B, Viscidi RP.

Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):935-40.

26.

Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia.

Bontkes HJ, de Gruijl TD, Bijl A, Verheijen RH, Meijer CJ, Scheper RJ, Stern PL, Burns JE, Maitland NJ, Walboomers JM.

J Gen Virol. 1999 Sep;80 ( Pt 9):2453-9.

PMID:
10501501
27.

A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings.

Jacobs MV, Walboomers JM, van Beek J, Voorhorst FJ, Verheijen RH, Meijer CJ, van den Brule AJ, Helmerhorst TJ, Snijders PJ.

Br J Cancer. 1999 Sep;81(1):114-21.

28.

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N.

J Pathol. 1999 Sep;189(1):12-9.

PMID:
10451482
29.

Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix.

de Gruijl TD, Bontkes HJ, van den Muysenberg AJ, van Oostveen JW, Stukart MJ, Verheijen RH, van der Vange N, Snijders PJ, Meijer CJ, Walboomers JM, Scheper RJ.

Eur J Cancer. 1999 Mar;35(3):490-7.

PMID:
10448305
30.

Screening for genital human papillomavirus: results from an international validation study on human papillomavirus sampling techniques.

de Sanjosé S, Bosch XF, Muñoz N, Chichareon S, Ngelangel C, Balagueró L, Jacobs MV, Meijer CJ, Walboomers JM.

Diagn Mol Pathol. 1999 Mar;8(1):26-31.

PMID:
10408790
31.

Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study.

Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, van der Linden HC, Voorhorst FJ, Kenemans P, Meijer CJ.

Lancet. 1999 Jul 3;354(9172):20-5. Erratum in: Lancet. 2015 Oct 10;386(10002):1446.

PMID:
10406360
32.

Interlaboratory agreement of different human papillomavirus DNA detection and typing assays in cervical scrapes.

Nindl I, Jacobs M, Walboomers JM, Meijer CJ, Pfister H, Wieland U, Meyer T, Stockfleth E, Klaes R, von Knebel Doeberitz M, Schneider A, Duerst M.

Int J Cancer. 1999 May 17;81(4):666-8. No abstract available.

33.

Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes.

de Gruijl TD, Bontkes HJ, Peccatori F, Gallee MP, Helmerhorst TJ, Verheijen RH, Aarbiou J, Mulder WM, Walboomers JM, Meijer CJ, van de Vange N, Scheper RJ.

Br J Cancer. 1999 Mar;79(7-8):1127-32.

34.

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.

Bontkes HJ, de Gruijl TD, Walboomers JM, Schiller JT, Dillner J, Helmerhorst TJ, Verheijen RH, Scheper RJ, Meijer CJ.

J Gen Virol. 1999 Feb;80 ( Pt 2):409-17.

PMID:
10073701
35.

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.

de Gruijl TD, Bontkes HJ, Walboomers JM, Coursaget P, Stukart MJ, Dupuy C, Kueter E, Verheijen RH, Helmerhorst TJ, Duggan-Keen MF, Stern PL, Meijer CJ, Scheper RJ.

J Gen Virol. 1999 Feb;80 ( Pt 2):399-408.

PMID:
10073700
36.

Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation.

Meijer GA, Hermsen MA, Baak JP, van Diest PJ, Meuwissen SG, Beliën JA, Hoovers JM, Joenje H, Snijders PJ, Walboomers JM.

J Clin Pathol. 1998 Dec;51(12):901-9.

37.

Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses.

Frisch M, Fenger C, van den Brule AJ, Sørensen P, Meijer CJ, Walboomers JM, Adami HO, Melbye M, Glimelius B.

Cancer Res. 1999 Feb 1;59(3):753-7.

38.

[Sexually transmitted infection as a cause of anal cancer].

Frisch M, Glimelius B, van den Brule AI, Wohlfahrt J, Meijer CJ, Walboomers JM, Goldman S, Svensson C, Adami HO, Melbye M.

Ugeskr Laeger. 1998 Nov 30;160(49):7109-17. Danish.

PMID:
9850615
39.

Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification.

Morré SA, Sillekens PT, Jacobs MV, de Blok S, Ossewaarde JM, van Aarle P, van Gemen B, Walboomers JM, Meijer CJ, van den Brule AJ.

Mol Pathol. 1998 Jun;51(3):149-54.

40.

Benign anal lesions, inflammatory bowel disease and risk for high-risk human papillomavirus-positive and -negative anal carcinoma.

Frisch M, Glimelius B, van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM, Adami HO, Melbye M.

Br J Cancer. 1998 Dec;78(11):1534-8.

41.

Differentiation and cell-type-restricted expression of HOXC4, HOXC5 and HOXC6 in myeloid leukemias and normal myeloid cells.

Bijl JJ, van Oostveen JW, Walboomers JM, Brink AT, Vos W, Ossenkoppele GJ, Meijer CJ.

Leukemia. 1998 Nov;12(11):1724-32.

42.

HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.

Bontkes HJ, van Duin M, de Gruijl TD, Duggan-Keen MF, Walboomers JM, Stukart MJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ, Stevens FR, Dyer PA, Sinnott P, Stern PL.

Int J Cancer. 1998 Oct 5;78(2):166-71.

44.

HPV typing and testing in gynaecological pathology: has the time come?

Meijer CJ, Helmerhorst TJ, Rozendaal L, van der Linden JC, Voorhorst FJ, Walboomers JM.

Histopathology. 1998 Jul;33(1):83-6. No abstract available.

PMID:
9726055
45.

p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.

Cruz IB, Snijders PJ, Meijer CJ, Braakhuis BJ, Snow GB, Walboomers JM, van der Waal I.

J Pathol. 1998 Apr;184(4):360-8.

PMID:
9664901
46.

Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women.

Krüger-Kjaer S, van den Brule AJ, Svare EI, Engholm G, Sherman ME, Poll PA, Walboomers JM, Bock JE, Meijer CJ.

Int J Cancer. 1998 May 29;76(5):613-9.

47.

Screening for cervical cancer.

Cuzick J, Meijer CJ, Walboomers JM.

Lancet. 1998 May 9;351(9113):1439-40. No abstract available.

PMID:
9593447
48.

Non-random allelic losses at 3p, 11p and 13q during HPV-mediated immortalization and concomitant loss of terminal differentiation of human keratinocytes.

Steenbergen RD, Hermsen MA, Walboomers JM, Meijer GA, Baak JP, Meijer CJ, Snijders PJ.

Int J Cancer. 1998 May 4;76(3):412-7.

49.

Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study.

de Gruijl TD, Bontkes HJ, Walboomers JM, Stukart MJ, Doekhie FS, Remmink AJ, Helmerhorst TJ, Verheijen RH, Duggan-Keen MF, Stern PL, Meijer CJ, Scheper RJ.

Cancer Res. 1998 Apr 15;58(8):1700-6.

50.

The viral origin of cervical cancer in Rabat, Morocco.

Chaouki N, Bosch FX, Muñoz N, Meijer CJ, El Gueddari B, El Ghazi A, Deacon J, Castellsagué X, Walboomers JM.

Int J Cancer. 1998 Feb 9;75(4):546-54.

Supplemental Content

Loading ...
Support Center